Mizuho analysts increased their price target on Amylyx Pharmaceuticals, with the news being reported by Benzinga on July 20, 2026.
5 reports, 2 independent
Updated Oct 17
Gone quiet
- Reports
- 5
- Developments
- 2
- Repetition
- 60%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Mizuho analysts increased their price target on Amylyx Pharmaceuticals, with the news being reported by Benzinga on July 20, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Citigroup raised its price objective for Amylyx Pharmaceuticals, alongside MarketBeat consensus ratings.1 source
Mizuho raised target price on Amylyx Pharmaceuticals; Benzinga reported the stock analysis.1 source
Keep exploring
The entities involved
-
Amylyx Pharmaceuticals
American biopharmaceutical company
Nothing else this week.
-
Mizuho
city in Gifu prefecture, Japan
Nothing else this week.
-
Benzinga
American news channel
Related events
- Benzinga reported on price target changes involving Annaly Capital Management.
- Benzinga reported stock analyst updates concerning the company Freshworks.
- BioMarin Pharmaceutical stock received updates on July 18, 2026, including a price target boost from Citigroup, reported by Benzinga.
- Morgan Stanley reduced its price target on DT Midstream, while Scotiabank set a new price objective, as reported by Benzinga.
- Benzinga reported on Cirrus Logic stock, which is listed on Nasdaq, following a price target cut by Susquehanna.